Maria Fardis

4 Patents

• US126114272026

  Treatment of NSCLC Patients Refractory for Anti-pd-1 Antibody

  Iovance Biotherapeutics, Inc.

  0 cites
• US125530292026

  Treatment of NSCLC Patients with Tumor Infiltrating Lymphocyte Therapies

  Iovance Biotherapeutics, Inc.

  0 cites
• US123433802025

  Expansion of Tils Utilizing AKT Pathways Inhibitors

  Iovance Biotherapeutics, Inc.

  0 cites
• US118195172023

  Methods of Using Tumor Infiltrating Lymphocytes in Double-refractory Melanoma

  IOVANCE BIOTHERAPEUTICS, Inc.

  0 cites